Mustang Bio to Participate in Three January 2021 Virtual Investor ConferencesGlobeNewsWire • 01/05/21
Notable Insider Buys In The Week Of Christmas: Foot Locker, GameStop, NetApp And MoreBenzinga • 12/26/20
Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients with Relapsed or Refractory B-cell Non-Hodgkin LymphomaGlobeNewsWire • 12/07/20
Is the Options Market Predicting a Spike in Mustang Bio (MBIO) Stock?Zacks Investment Research • 12/04/20
Mustang Bio to Host Key Opinion Leader Call on MB-106 for the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin LymphomaGlobeNewsWire • 12/01/20
Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation for Its Lentiviral Gene Therapy for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)GlobeNewsWire • 11/24/20
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 11/06/20
Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/04/20
Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients with PSCA-positive Castration Resistant Prostate CancerGlobeNewsWire • 10/26/20
Mustang Bio Announces MB-105 Data Selected for Presentation at the Virtual 27th Annual Prostate Cancer Foundation Scientific RetreatGlobeNewsWire • 10/08/20
Mustang Bio to Participate in Chardan’s Virtual 4th Annual Genetic Medicines Conference 2020GlobeNewsWire • 10/01/20
Mustang Bio Announces Orphan Drug Designation for MB-207 for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) in Previously Transplanted PatientsGlobeNewsWire • 09/22/20
Mustang Bio Announces Rare Pediatric Disease Designation for MB-207 for the Treatment of X-linked Severe Combined Immunodeficiency in Previously Transplanted PatientsGlobeNewsWire • 08/31/20
Mustang Bio: Slow, Steady Progress Towards Multiple Gene And CAR-T Therapy GoalsSeeking Alpha • 08/25/20
Do Options Traders Know Something About Mustang Bio (MBIO) Stock We Don't?Zacks Investment Research • 08/18/20
Mustang Bio to Present at the Virtual Fortress Biotech Corporate Access SummitGlobeNewsWire • 08/17/20
Mustang Bio Reports Second Quarter 2020 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 08/10/20